08
Azivudine, which has been approved for phase IlI clinical trials for more than two years, is expected to become China's first oral anti-COVID-19 drug with fully independent intellectual property. On July 15, Henan Genuine BiotechCo., LTD. announced that it had recently formally submitted the marketingapplication for Azvudine for the treatment of COVID-19 to the National Medical Products Adminis...
04
Recently, led by Professor Yang Jianjun of the First Affiliated Hospital of Zhengzhou University, Professor Shi Yun of Nanjing University and Director Xu Zhengfeng of Nanjing Maternal and Child Health Hospital, the cognitive neuroscience research team published its research results entitled Enhancing GLuN2A-type NMDA Receptors Impairs Long-term Synaptic Plasticity and Learning and Memory online...
01
According to the latest news from the 11th World Games being held in Birmingham, Alabama, China Dutch team led by teachers and students of Zhengzhou University has got the fifth place
28
Recently, the professional institution of higher education evaluation, Shanghai Ranking, officially released the Academic Ranking of Chinese Universities of 2022, with Zhejiang University, Zhongshan University and Tsinghua University occupying the top three positions. The number of world-class disciplines of Zhengzhou University ranked 33rd among mainland universities, an increase of 9 places o...